ASCO 2022: Updates in Gastrointestinal Cancer

The American Society of Clinical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from some of the leading experts in gastrointestinal cancer, as they discuss the biggest trials and hot topics from the meeting. For pancreatic cancer, we heard from Dr Vinod Balachandran about mRNA neoantigen vaccines and Prof. Rainer Fietkau about the CONKO-007 trial. Dr Ian Chau discussed the role of CAR T-cell therapies in the treatment of gastric cancer and gave us an update on CheckMate-648. For colorectal cancer, we heard from Dr Christine Parseghian about anti-EGFR rechallenge therapy, Dr Richard Kim about the KEYNOTE-651 trial, Prof. Jean-Pierre Gerard about the OPERA trial, and Prof. Chiara Cremolini and Dr Takayuki Yoshino the results and impact of the PARADIGM trial.